Hypertension (13.6)-(40.7)-(76.2), MI (0)-(2.2)-(9.1), angina pectoris (0)-(1.1)-(4.0), stroke (0)-(1.1)-(8.0), peripheral artery disease (0)-(1.1)-(5.0), and CHF (0)-(1.1)-(5.0)
CVD: cardiovascular disease; RA: rheumatoid arthritis; RF: rheumatoid factor; EAM: extraarticular manifestations; GC: glucocorticoids; N/A: not available; MI: myocardial infarction; CHF: congestive heart failure; TGL: triglycerides; CAD: coronary artery disease; BMI: body mass index; T2DM: type 2 diabetes mellitus; CRP: C-reactive protein; RADAR: rapid assessment of disease activity in rheumatology; HAQ-Di: health assessment questionnaire disability index; MTX: methotrexate; ESR: Erythrocyte Sedimentation Rate; DAS-28: Disease Activity Score-28; SSZ: sulfasalazine; vWF: von Willebrand Factor; IMT: intima-medial thickness; MetS: metabolic syndrome; SDAI: simplified disease activity index; TC: total cholesterol; anti-CCP: anti-cyclic citrullinated peptide antibodies; aCL: anticardiolipins antibodies; anti-B2GPI: anti-2glycoprotein I antibodies; anti-HSP 60/65: anti-heat shock proteins 60/65 antibodies; anti-LPL: antiLipoprotein lipase antibodies; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol.
aOnly descriptive study, which evaluated causes of mortality in adult patients with RA.
bBy echocardiogram and gammagraphy.
cData from patients with RA 14/37 (37.8).
dData from patients with hyperhomocysteinemia (>15 μmol/L).
eExclusion criteria: patient with traditional cardiovascular risk factors.
fOnly female were included, each with at least 5 years of duration of the disease and between 35 and 54 years of age.
gNot CVD subphenotype measured. Prevalence regarding presence of atherosclerosis plaque.
hOnly female were included.
iExclusion criteria: smoking, diabetes and hypertension pregnancy, renal failure, chronic hepatopathy, nephrotic syndrome, hypothyroidism and use of statins/fibrates.
jRA patients versus controls.
lExclusion criteria: smoking, diabetes, and hypertension.
mHigh blood pressure was defined above 130/85 mmHg.
nThe objective was to analyze causes and direct costs of hospitalization of Colombian patients with RA.
oSample population was originally from Northwestern Colombia. They are considered ethnically different.
pExclusion criteria: any symptoms of heart disease or risk factors for CVD.
qSubjects over 60 years were excluded.
rOnly cohort, 6 years followup. Low mortality rate 9/32 (5.2%).
sThree age group (<40 y)-(40–59 y)-(>60 y). Elder people (>60 y) have more probability to develop CVD independent of RA. †Mean ± standard deviation. ‡Median (interquartile range).
#Prevalence of CVD regarding the only subphenotype described. § values < 0.05 were considered significant.